2013年1月4日,

风险基金成员概要文件共享此概要:BR风险基金(BRV)约翰逊’年代早期风险资本基金。操作完全由一组MBA学生,BRV通常投资250000美元在美国各行各业的高成长型企业。最初由大学捐款,BRV是一个真正的长青基金,回收所有收益用于再投资。随着启动资金投资于有前途的新公司,BRV也是通往康奈尔技术通过提供投资伙伴独特的创新。通过建立关系与其他投资者,BRV有能力创造新的辛迪加机会以及参与这些基金。投资从BRV不仅会带来的支持世界上的顶级商学院之一,而且还能够利用任何康奈尔’的年代,许多资源。亚伦假日首席运营官和基金经理BR成功启动和运行一个软件后的风险基金咨询公司当了两年学生莫尔豪斯学院,亚伦于2004年开始他的职业生涯是在高盛(Goldman Sachs)。在高盛亚伦支持程序交易部门。2008年,亚伦加入了产品开发主管GFI集团重新设计公司’年代外汇期权交易技术平台。而在纽约,亚伦曾在三个董事会:iMentor,哈莱姆独立生活中心(HILC)和DSJ合作社董事会。 At Cornell, Aaron leads the eLab, an incubator that accelerates 9 start-ups. Aaron is also a member of the Entrepreneurship@Cornell student board of directors and leads an initiative to launch a university wide mobile application that uses location based technology to connect Cornell’s community of alumni, students, and faculty. During the 2010 winter break, Aaron developed an access to venture capital strategy and wrote a white paper on investing in biopharmaceutical startups for Ezra Pharmaceuticals, a start-up that leverages intellectual property from Weill Cornell Medical School. The work for Ezra was an effort to help the start-up raise $10M in Series A financing. During the 2011 spring break, Aaron led a team of 7 MBAs in the New Orleans IdeaVillage competition where his team created a sales pipeline and gained access to distribution in Asia for a local entrepreneur who manufactured high-end spa equipment. This summer, Aaron will be working for a NYC venture capital backed start-up. Aaron is a MLT Fellow and a Consortium for Graduate Study in Management Fellow. Representative Investments Adenios technology both raises and lowers the permeability of the blood brain barrier to precisely control the delivery of existing drugs. The technology, spun out of Cornell University, can be paired with unmodified current therapeutics to either improve or block delivery of multiple compounds into the brain. e2e Materials , based in Ithaca, NY develops, designs, engineers and produces proprietary biocomposites for the furniture, cabinetry and other markets. e2e’s proprietary composites are made from soy flour and natural grass fiber such as jute, flax and kenaf. Products made from e2e’s biocomposite are stronger, lighter, safer and cheaper than those made from formaldehyde-laden wood composites. Additionally, e2e uses only a small fraction of the energy required for wood composites, saving billions of pounds of CO2. GNS Healthcare is a healthcare IT company that applies machine learning and simulation technology to optimize patient treatment in partnership with health insurance companies, pharmacy benefit managers, and pharmaceutical & biotech companies. GNS Healthcare is the information guru between drug makers and drug buyers matching drugs to patients to deliver on the promise of “smart” medicine. NovaSterilis is committed to providing a new level of patient safety and product performance through the development of a new, emerging technology. The development of the supercritical carbon dioxide as a solvent for the NovaKill sterilent allows the biomedical community to achieve sterilization without compromising the product’s integrity. Aaron participated in the FundingPost event: NYC Winter VC & Angel Eventon Tuesday, December 6, 2011 in NY, Sponsored by WeiserMazars To list your Company on our website and make your profile available to Aaron and 7,500+ other VCs and Angel Investors, Click Here. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles: